Susceptibility Testing for Mycobacteria
Open Access
- 15 November 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (5) , 1209-1215
- https://doi.org/10.1086/317441
Abstract
Mycobacterial susceptibility testing is important for the management of patients with tuberculosis and those with disease caused by certain nontuberculous mycobacteria. To help standardize methods used in the clinical microbiology laboratory for testing susceptibility of mycobacteria, the National Committee for Clinical Laboratory Standards (NCCLS) recently updated NCCLS document M24-T (published in 1995), which is the tentative standard for antimycobacterial susceptibility testing of Mycobacterium tuberculosis. The second edition of the NCCLS tentative standard (document M24-T2) differs considerably from the initial document. It contains revised guidelines for the testing of M. tuberculosis complex and newly proposed guidelines for the testing of some nontuberculous mycobacteria, including the rapidly growing mycobacteria (Mycobacterium fortuitum group, Mycobacterium chelonae, and Mycobacterium abscessus), Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium marinum, as well as Nocardia species and other aerobic actinomycetes. The recommendations for mycobacterial susceptibility testing that are outlined in NCCLS document M24-T2 are reviewed.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the BBL MGIT (Mycobacterial Growth Indicator Tube) AST SIRE System for Antimycobacterial Susceptibility Testing of Mycobacterium tuberculosis to 4 Primary Antituberculous DrugsArchives of Pathology & Laboratory Medicine, 2000
- Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Respiratory Viral Infections in Immunocompetent and Immunocompromised PersonsPublished by Elsevier ,1997
- Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal PopulationThe Journal of Infectious Diseases, 1996
- Treatment of Mycobacterium avium Complex Infection: Do the Results of In Vitro Susceptibility Tests Predict Therapeutic Outcome in Humans?The Journal of Infectious Diseases, 1996
- Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated diseaseAntimicrobial Agents and Chemotherapy, 1995
- Clarithromycin Therapy for BacteremicMycobacterium aviumComplex DiseaseAnnals of Internal Medicine, 1994
- Rifampin-Resistant Mycobacterium kansasiiClinical Infectious Diseases, 1994
- Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC systemAntimicrobial Agents and Chemotherapy, 1992
- Clarithromycin Minimal Inhibitory and Bactericidal Concentrations againstMycobacterium aviumAmerican Review of Respiratory Disease, 1992